Literature DB >> 1699434

Bronchial epithelial cells exposed to isocyanates potentiate activation and proliferation of T-cells.

S Mattoli1, S Miante, F Calabrò, M Mezzetti, A Fasoli, L Allegra.   

Abstract

Bronchial epithelial cells release chemotactic factors for lymphocytes and express HLA-DR antigens. Thus they may contribute to the T-cell-mediated inflammatory responses involved in a number of pulmonary diseases such as asthma. In this study, the in vitro exposure of human bronchial epithelial cells to toluene 2,4-diisocyanate (TDI), an inflammatory and asthmogenic stimulus presumed to act at least in part through immunological mechanisms, provoked cell damage followed by proliferation of the cells that survived the injury. At the time of the proliferative response, epithelial cells released factors that upregulated the activation and proliferation of T lymphocytes presensitized by antigen receptor triggering. The T-cell activating factors were interleukin (IL) 1- and 6-like substances, as demonstrated by the ability of specific antisera to inhibit most of the biological effect, and by the ability of recombinant IL-1 and IL-6 to reproduce it. Appreciable amounts of immunoreactive IL-1 and IL-6 were indeed recovered in the supernatants of TDI-exposed epithelial cells. The release of these cytokines may represent an important mechanism by which epithelial cells respond to some environmental stimuli and contribute to the persistence of inflammatory responses in the airways.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699434     DOI: 10.1152/ajplung.1990.259.4.L320

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells.

Authors:  O J Kwon; B T Au; P D Collins; J N Baraniuk; I M Adcock; K F Chung; P J Barnes
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

2.  Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.

Authors:  L Churchill; B Friedman; R P Schleimer; D Proud
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

3.  Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation.

Authors:  Jing Wu; Rongqi Duan; Huibi Cao; Deborah Field; Catherine M Newnham; David R Koehler; Noe Zamel; Melanie A Pritchard; Paul Hertzog; Martin Post; A Keith Tanswell; Jim Hu
Journal:  Cell Res       Date:  2008-06       Impact factor: 25.617

4.  Poly-L-Arginine Acts Synergistically with LPS to Promote the Release of IL-6 and IL-8 via p38/ERK Signaling Pathways in NCI-H292 Cells.

Authors:  Xiao-Yun Fan; Bing Chen; Zhao-Shuang Lu; Zi-Feng Jiang; Sheng-Quan Zhang
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

5.  Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33.

Authors:  Monique A M Willart; Kim Deswarte; Philippe Pouliot; Harald Braun; Rudi Beyaert; Bart N Lambrecht; Hamida Hammad
Journal:  J Exp Med       Date:  2012-07-16       Impact factor: 14.307

Review 6.  Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling Reviewed.

Authors:  Paul M Peeters; Emiel F Wouters; Niki L Reynaert
Journal:  J Immunol Res       Date:  2015-08-19       Impact factor: 4.818

7.  LPS Cooperates with Poly-L-Arginine to Promote IL-6 and IL-8 Release via the JNK Signaling Pathway in NCI-H292 Cells.

Authors:  Ling-Ling Zhang; Bing Chen; Xiao-Yun Fan; Sha-Sha Wu; Sheng-Quan Zhang; Hui-Mei Wu
Journal:  J Immunol Res       Date:  2016-12-26       Impact factor: 4.818

8.  Toluene diisocyanate exposure induces airway inflammation of bronchial epithelial cells via the activation of transient receptor potential melastatin 8.

Authors:  Joo-Hee Kim; Young-Sook Jang; Seung-Hun Jang; Ki-Suck Jung; Seung-Hyun Kim; Young-Min Ye; Hae-Sim Park
Journal:  Exp Mol Med       Date:  2017-03-03       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.